Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study.

Mircea PolosanMarc Rabbani Michael Cronquist ChristensenKenneth SimonsenHongye Ren

Published in: Neuropsychiatric disease and treatment (2022)

Clinically relevant and sustained improvements in overall functioning, depressive symptoms, cognitive symptoms, and cognitive performance were observed in patients with MDD treated with vortioxetine for 6 months in routine clinical practice settings in France.

Keyphrases

major depressive disorder
clinical practice
bipolar disorder
depressive symptoms
randomized controlled trial
systematic review
sleep quality
social support
physical activity